125742 S1 M5 c4591001 A report cci any malignancy
Document text
CCI_Any malignancy MedDRA Dictionary Version: 230 Status: ACTIVETerm Name: CCI_Any malignancyCode: 90002950Extension: CCIReport Date/Time: 27-Oct-2020:10:42:05 AM EDT Term Code Level Category Weight Scope Ovarian germ cell embryonal carcinoma stage I 10033196 PT Ovarian germ cell choriocarcinoma stage IV 10033195 PTOvarian germ cell choriocarcinoma stage III 10033191 PTOvarian germ cell choriocarcinoma stage II 10033187 PTOvarian germ cell choriocarcinoma stage I 10033183 PTOvarian germ cell choriocarcinoma 10073262 PTOvarian germ cell cancer stage IV 10061897 PTOvarian germ cell cancer stage III 10061896 PTOvarian germ cell cancer stage II 10061895 PTOvarian germ cell cancer stage I 10061894 PTLip and/or oral cavity cancer 10061523 PTLinitis plastica 10024520 PTLight chain disease 10024459 PTLeptomeningeal myelomatosis 10078282 PTLeiomyosarcoma recurrent 10024194 PTLeiomyosarcoma 10024189 PTLaryngeal squamous cell carcinoma 10023856 PTLaryngeal cancer stage IV 10023833 PTLaryngeal cancer stage III 10023832 PTLaryngeal cancer stage II 10023831 PTLaryngeal cancer stage I 10023830 PTLaryngeal cancer stage 0 10023829 PTLaryngeal cancer recurrent 10023828 PTLaryngeal cancer 10023825 PTLarge cell lung cancer stage IV 10023780 PTLarge cell lung cancer stage III 10023779 PTLarge cell lung cancer stage II 10023778 PTLarge cell lung cancer stage I 10023777 PTLarge cell lung cancer stage 0 10023776 PTLarge cell lung cancer recurrent 10023775 PTLarge cell lung cancer 10023774 PTLangerhans' cell histiocytosis 10069698 PTKeratinising squamous cell carcinoma of nasopharynx 10073324 PTKaposi's sarcoma classical type 10023288 PTKaposi's sarcoma 10023284 PTAdenosquamous cell lung cancer stage 0 10001248 PTAdenosquamous cell lung cancer recurrent 10001247 PTAdenosquamous cell lung cancer 10001245 PTAdenosquamous cell carcinoma 10068873 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023879 Adenosquamous carcinoma of vagina 10073978 PT Adenosquamous carcinoma of the cervix 10001244 PT Adenoid cystic carcinoma of salivary gland 10073370 PTExternal ear neoplasm malignant 10082277 PTAdenoid cystic carcinoma 10053231 PTAdenocarcinoma pancreas 10052747 PTAdenocarcinoma of the cervix 10001197 PTAdenocarcinoma of salivary gland 10068068 PTAdenocarcinoma of colon 10001167 PTAdenocarcinoma of appendix 10073359 PTAdenocarcinoma gastric 10001150 PTAdenocarcinoma 10001141 PTAcinic cell carcinoma of salivary gland 10073369 PTAcinar cell carcinoma of pancreas 10073363 PTAbdominal wall neoplasm malignant 10071023 PTYolk sac tumour site unspecified 10048251 PTVulvar adenocarcinoma 10063536 PTVulval cancer stage IV 10047749 PTVulval cancer stage III 10047748 PTVulval cancer stage II 10047747 PTVulval cancer stage I 10047746 PTVulval cancer stage 0 10047745 PTVulval cancer recurrent 10047744 PTVulval cancer 10047741 PTVaginal cancer stage IVB 10046895 PTVaginal cancer stage IVA 10046894 PTVaginal cancer stage III 10046893 PTVaginal cancer stage II 10046892 PTVaginal cancer stage I 10046891 PTVaginal cancer stage 0 10046890 PTVaginal cancer recurrent 10046889 PTVaginal cancer 10046885 PTVaginal adenocarcinoma 10065349 PTUterine carcinoma in situ 10046770 PTUterine cancer 10046766 PTUrinary tract carcinoma in situ 10061396 PTUrinary bladder sarcoma 10051690 PTUrethral cancer recurrent 10046435 PTUrethral cancer 10046431 PTUreteric cancer regional 10046397 PTUreteric cancer recurrent 10046396 PTUreteric cancer local 10046393 PTUreteric cancer 10046392 PTUndifferentiated sarcoma 10045515 PTUndifferentiated nasopharyngeal carcinoma 10073328 PTUndifferentiated carcinoma of colon 10073362 PTTumour of ampulla of Vater 10073851 PTTumour invasion 10064390 PTTumour budding 10076969 PTTubular breast carcinoma 10073104 PTTriple negative breast cancer 10075566 PTTransitional cell carcinoma urethra 10044426 PTTransitional cell carcinoma recurrent 10077051 PTOvarian germ cell cancer 10061893 PTOvarian epithelial cancer stage IV 10033164 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023880 Ovarian epithelial cancer stage III 10033163 PT Ovarian epithelial cancer stage II 10033162 PT Ovarian epithelial cancer stage I 10033161 PT Ovarian epithelial cancer recurrent 10033160 PT Ovarian epithelial cancer 10061328 PT Ovarian endometrioid carcinoma 10073269 PT Ovarian embryonal carcinoma 10056266 PT Ovarian dysgerminoma stage unspecified 10052759 PT Ovarian dysgerminoma stage IV 10033156 PT Ovarian dysgerminoma stage III 10033152 PT Ovarian dysgerminoma stage II 10033148 PT Ovarian dysgerminoma stage I 10033144 PT Ovarian clear cell carcinoma 10073268 PT Ovarian cancer stage IV 10070908 PT Ovarian cancer stage III 10070907 PT Ovarian cancer stage II 10070906 PT Ovarian cancer stage I 10070905 PT Ovarian cancer recurrent 10066697 PT Ovarian cancer 10033128 PT Osteosarcoma recurrent 10031296 PT Osteosarcoma 10031291 PT Oropharyngeal squamous cell carcinoma 10031112 PT Oropharyngeal lymphoepithelioma 10031104 PT Oropharyngeal cancer stage IV 10064099 PT Oropharyngeal cancer stage III 10031102 PT Oropharyngeal cancer stage II 10031101 PT Oropharyngeal cancer stage I 10031100 PT Oropharyngeal cancer stage 0 10031099 PT Oropharyngeal cancer recurrent 10031098 PT Oropharyngeal cancer 10031096 PT Optic glioma 10073338 PT Oligodendroglioma 10030286 PT Oligoastrocytoma 10073131 PT Hormone receptor positive breast cancer 10083234 PT Oesophageal squamous cell carcinoma stage IV 10030192 PT Oesophageal squamous cell carcinoma stage III 10030191 PT Oesophageal squamous cell carcinoma stage II 10030190 PT Oesophageal squamous cell carcinoma stage I 10030189 PT Oesophageal squamous cell carcinoma stage 0 10030188 PT Oesophageal squamous cell carcinoma recurrent 10030187 PT Oesophageal squamous cell carcinoma 10061534 PT Oesophageal carcinoma stage 0 10030162 PT Oesophageal carcinoma recurrent 10030159 PT Oesophageal carcinoma 10030155 PT Oesophageal adenocarcinoma stage IV 10030145 PT Oesophageal adenocarcinoma stage III 10030144 PT Oesophageal adenocarcinoma stage II 10030143 PT Oesophageal adenocarcinoma stage I 10030142 PT Oesophageal adenocarcinoma stage 0 10030141 PT Oesophageal adenocarcinoma recurrent 10030140 PT Oesophageal adenocarcinoma 10030137 PT Ocular haemangiopericytoma 10057416 PT NUT midline carcinoma 10078295 PT Non-small cell lung cancer stage IV 10029522 PT Non-small cell lung cancer stage IIIB 10029521 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023881 Non-small cell lung cancer stage IIIA 10029520 PT Non-small cell lung cancer stage III 10029519 PT Non-small cell lung cancer stage II 10029518 PT Non-small cell lung cancer stage I 10029517 PT Non-small cell lung cancer stage 0 10029516 PT Non-small cell lung cancer recurrent 10029515 PT Non-small cell lung cancer 10061873 PT Non-secretory adenoma of pituitary 10029556 PTNon-renal cell carcinoma of kidney 10061872 PTNonkeratinising carcinoma of nasopharynx 10073325 PTNongerminomatous germ cell tumour of the CNS 10065871 PTNeurofibrosarcoma recurrent 10029277 PTInflammatory carcinoma of breast recurrent 10021977 PTImmune reconstitution inflammatory syndrome associated Kaposi's sarcoma 10072796 PTHypopharyngeal cancer stage IV 10021049 PTHypopharyngeal cancer stage III 10021048 PTHypopharyngeal cancer stage II 10021047 PTHypopharyngeal cancer stage I 10021046 PTHypopharyngeal cancer stage 0 10021045 PTHypopharyngeal cancer recurrent 10021044 PTHypopharyngeal cancer 10021042 PTHuerthle cell carcinoma 10066136 PTHormone-refractory prostate cancer 10062904 PTHormone-dependent prostate cancer 10071119 PTHormone refractory breast cancer 10076935 PTHistiocytic sarcoma 10076876 PTHistiocytic medullary reticulosis 10068785 PTHER2 positive gastric cancer 10066896 PTHER2 positive breast cancer 10065430 PTHepatocellular carcinoma 10073071 PTHepatoblastoma recurrent 10019823 PTHepatoblastoma 10062001 PTHepatobiliary cancer in situ 10073074 PTHepatobiliary cancer 10073073 PTHepatic cancer stage IV 10059325 PTHepatic cancer stage III 10059324 PTHepatic cancer stage II 10059319 PTHepatic cancer stage I 10059318 PTHepatic cancer recurrent 10073070 PTHepatic cancer 10073069 PTHepatic angiosarcoma 10067388 PTHeavy chain disease 10019350 PTHead and neck cancer stage IV 10071536 PTHead and neck cancer stage III 10071537 PTHead and neck cancer stage II 10071538 PTHead and neck cancer stage I 10071539 PTHead and neck cancer 10067821 PTHaematological malignancy 10066476 PTHaemangiopericytoma of meninges 10018826 PTHaemangiopericytoma 10018825 PTGlottis carcinoma 10018395 PTGliosarcoma 10018340 PTGliomatosis cerebri 10066254 PTGlioma 10018338 PTGlioblastoma multiforme 10018337 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023882 Transitional cell carcinoma 10044412 PT Transitional cell cancer of the renal pelvis and ureter regional 10044411 PT Transitional cell cancer of the renal pelvis and ureter recurrent 10044410 PT Transitional cell cancer of the renal pelvis and ureter localised 10044408 PT Transitional cell cancer of the renal pelvis and ureter 10044407 PT Tracheal cancer 10044285 PT Tonsil cancer 10044002 PT Tongue neoplasm malignant stage unspecified 10043966 PT Tongue carcinoma stage IV 10058433 PT Tongue carcinoma stage III 10058432 PT Tongue carcinoma stage II 10058431 PT Tongue carcinoma stage I 10058430 PT Tongue carcinoma stage 0 10058429 PT Tongue cancer recurrent 10071251 PT Thyroid cancer stage IV 10071030 PT Thyroid cancer stage III 10071029 PT Thyroid cancer stage II 10071028 PT Thyroid cancer stage I 10071027 PT Thyroid cancer stage 0 10070567 PT Thyroid cancer recurrent 10072162 PT Thyroid cancer 10066474 PT Thymoma malignant recurrent 10043674 PT Thymoma malignant 10061031 PT Throat cancer 10043515 PT Testis cancer recurrent 10069813 PT Testis cancer 10057644 PT Testicular yolk sac tumour stage III 10043359 PT Testicular yolk sac tumour stage II 10043358 PT Glioblastoma 10018336 PT Gingival cancer 10067807 PT Germ cell cancer 10061184 PT Genitourinary melanoma 10077166 PT Genital neoplasm malignant female 10018160 PT Genital cancer male in situ 10073124 PT Genital cancer male 10073116 PT Gastrooesophageal cancer 10062878 PT Gastrointestinal stromal tumour 10051066 PT Gastrointestinal melanoma 10077167 PT Gastrointestinal carcinoma in situ 10061168 PT Gastrointestinal carcinoma 10017940 PT Gastrinoma malignant 10051709 PT Gastric sarcoma 10055008 PT Colon cancer stage 0 10063523 PT Colon cancer recurrent 10009952 PT Colon cancer 10009944 PT CNS germinoma 10065852 PT Clear cell sarcoma of the kidney 10009253 PT Clear cell sarcoma of soft tissue 10073140 PT Clear cell renal cell carcinoma 10073251 PT Clear cell endometrial carcinoma 10009252 PT Testicular yolk sac tumour stage I 10043357 PT Testicular yolk sac tumour 10073121 PT Testicular seminoma (pure) stage III 10043352 PT Testicular seminoma (pure) stage II 10043351 PT Testicular seminoma (pure) stage I 10043350 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023883 Testicular seminoma (pure) 10062124 PT Testicular malignant teratoma stage III 10043341 PT Testicular malignant teratoma stage II 10043340 PT Testicular malignant teratoma stage I 10043339 PT Testicular malignant teratoma 10073120 PT Extragonadal primary seminoma (pure) stage I 10015811 PT Extragonadal primary seminoma (pure) 10073057 PT Extragonadal primary non-seminoma stage IV 10015810 PT Extragonadal primary non-seminoma stage III 10015809 PT Extragonadal primary non-seminoma stage II 10015806 PT Extragonadal primary non-seminoma stage I 10015805 PT Extragonadal primary non-seminoma 10061849 PT Testicular leiomyosarcoma 10057340 PT Testicular germ cell tumour mixed stage III 10043333 PT Testicular germ cell tumour mixed stage II 10043332 PT Testicular germ cell tumour mixed stage I 10043331 PT Testicular germ cell tumour mixed 10073119 PT Testicular germ cell cancer 10061378 PT Testicular embryonal carcinoma stage III 10043311 PT Testicular embryonal carcinoma stage II 10043310 PT Testicular embryonal carcinoma stage I 10043309 PT Testicular embryonal carcinoma 10062123 PT Testicular choriocarcinoma stage III 10043305 PT Testicular choriocarcinoma stage II 10043304 PT Testicular choriocarcinoma stage I 10043303 PT Testicular choriocarcinoma recurrent 10069812 PT Testicular choriocarcinoma 10062122 PT Synovial sarcoma recurrent 10042867 PT Synovial sarcoma 10042863 PT Stewart-Treves syndrome 10059498 PT Squamous endometrial carcinoma 10041883 PT Squamous cell carcinoma of the vulva 10041875 PT Squamous cell carcinoma of the vagina 10041866 PT Squamous cell carcinoma of the tongue 10041865 PT Squamous cell carcinoma of the oral cavity 10041857 PT Squamous cell carcinoma of the hypopharynx 10041849 PT Squamous cell carcinoma of the cervix 10041848 PT Squamous cell carcinoma of pharynx 10066471 PT Squamous cell carcinoma of lung 10041826 PT Squamous cell carcinoma of head and neck 10060121 PT Spindle cell sarcoma 10049067 PT Spinal meningioma malignant 10041580 PT Spermatocytic seminoma 10073118 PT Somatostatinoma 10041329 PT Solid pseudopapillary tumour of the pancreas 10069345 PT Soft tissue sarcoma 10075333 PT Small intestine leiomyosarcoma 10041127 PT Small intestine carcinoma stage IV 10059372 PT Small intestine carcinoma stage III 10059371 PT Small intestine carcinoma stage II 10059370 PT Small intestine carcinoma stage I 10059369 PT Small intestine carcinoma stage 0 10059368 PT Small intestine carcinoma recurrent 10041124 PT Small intestine carcinoma 10054184 PT Small intestine adenocarcinoma 10073373 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023884 Small cell lung cancer recurrent 10041070 PT Small cell lung cancer limited stage 10041069 PT Small cell lung cancer extensive stage 10041068 PT Small cell lung cancer 10041067 PT Small cell carcinoma of the cervix 10041057 PT Small cell carcinoma 10041056 PT Signet-ring cell carcinoma 10057266 PT Serous cystadenocarcinoma ovary 10054913 PT Cystadenocarcinoma pancreas 10065908 PT Seminoma 10039956 PT Secretory adenoma of pituitary 10039893 PT Second primary malignancy 10039801 PT Scrotal cancer 10039744 PT Sarcomatosis 10039500 PT Clear cell carcinoma of cervix 10074909 PT Choroid plexus carcinoma 10067478 PT Choroid melanoma 10008773 PT Choriocarcinoma 10008757 PT Chordoma 10008747 PT Chondrosarcoma recurrent 10008738 PT Chondrosarcoma 10008734 PT Cholangiosarcoma 10077861 PT Cholangiocarcinoma 10008593 PT Cervix carcinoma stage IV 10008348 PT Cervix carcinoma stage III 10008347 PT Cervix carcinoma stage II 10008346 PT Cervix carcinoma stage I 10008345 PT Cervix carcinoma stage 0 10061809 PT Cervix carcinoma recurrent 10008344 PT Cervix carcinoma 10008342 PT Central nervous system neuroblastoma 10073130 PT Central nervous system melanoma 10077160 PT Cardiac teratoma 10057456 PT Cardiac neoplasm malignant 10061025 PT Carcinoma in situ of trachea 10007401 PT Carcinoma in situ of penis 10007384 PT Carcinoma in situ of eye 10007368 PT Carcinoma in situ 10061450 PT Carcinoma ex-pleomorphic adenoma 10077435 PT Cancer in remission 10065305 PT Bronchioloalveolar carcinoma 10058354 PT Bronchial carcinoma 10006417 PT Breast sarcoma recurrent 10068584 PT Breast sarcoma 10068582 PT Renal cancer recurrent 10038390 PT Renal cancer 10038389 PT Refractory cancer 10070308 PT Recurrent cancer 10038111 PT Rectosigmoid cancer stage IV 10038099 PT Rectosigmoid cancer stage III 10038098 PT Rectosigmoid cancer stage II 10038097 PT Rectosigmoid cancer stage I 10038096 PT Neuroendocrine carcinoma of the bladder 10078341 PT Neuroendocrine carcinoma 10057270 PT Neuroblastoma recurrent 10066595 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023885 Neuroblastoma 10029260 PT Nephroblastoma 10029145 PT Neoplasm malignant 10028997 PT Nasopharyngeal cancer stage IV 10028792 PTNasopharyngeal cancer stage III 10028791 PTNasopharyngeal cancer stage II 10028790 PTNasopharyngeal cancer stage I 10028789 PTNasopharyngeal cancer stage 0 10028788 PTNasopharyngeal cancer recurrent 10028787 PTNasopharyngeal cancer 10061306 PTNasal sinus cancer 10028767 PTNasal cavity cancer 10028729 PTMyxoid liposarcoma 10073137 PTMyxofibrosarcoma 10066948 PTMyelofibrosis 10028537 PTMyeloblastoma 10051141 PTMusculoskeletal cancer 10077675 PTMultiple endocrine neoplasia Type 2 10073149 PTMueller's mixed tumour 10066057 PTMucoepidermoid carcinoma of salivary gland 10073371 PTMucoepidermoid carcinoma 10057269 PTMucinous endometrial carcinoma 10028076 PTMalignant respiratory tract neoplasm 10061270 PTMalignant polyp 10078695 PTMalignant pituitary tumour 10026672 PTMalignant peritoneal neoplasm 10061269 PTMalignant pericardial neoplasm 10054946 PTMalignant palate neoplasm 10026663 PTMalignant ovarian cyst 10026662 PTMalignant oligodendroglioma 10026659 PTMalignant nipple neoplasm male 10053128 PTMalignant nipple neoplasm female 10053129 PTMalignant nipple neoplasm 10062051 PTMalignant nervous system neoplasm 10061268 PTMalignant neoplasm progression 10051398 PTMalignant neoplasm papilla of Vater 10077303 PTMalignant neoplasm of uterine adnexa 10026616 PTMalignant neoplasm of unknown primary site 10073059 PTMalignant neoplasm of thymus 10026533 PTMalignant neoplasm of thorax 10026532 PTMalignant neoplasm of spinal cord 10026472 PTMalignant neoplasm of spermatic cord 10026470 PTMalignant neoplasm of seminal vesicle 10068124 PTMalignant neoplasm of retina 10026432 PTMalignant neoplasm of renal pelvis 10026426 PTMalignant neoplasm of pleura 10026351 PTMalignant neoplasm of placenta 10026350 PTMalignant neoplasm of paraurethral glands 10026326 PTMalignant neoplasm of orbit 10026183 PTMalignant neoplasm of lacrimal gland 10026031 PTMalignant neoplasm of lacrimal duct 10026030 PTMalignant neoplasm of islets of Langerhans 10025997 PTMalignant neoplasm of eyelid 10063693 PTMalignant neoplasm of eye 10025910 PTMalignant neoplasm of cornea 10025871 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023886 Malignant neoplasm of conjunctiva 10025861 PT Malignant neoplasm of choroid 10025839 PT Malignant neoplasm of ampulla of Vater 10025697 PT Malignant muscle neoplasm 10062050 PTMalignant middle ear neoplasm 10061267 PTMalignant mesenteric neoplasm 10067369 PTMalignant mesenchymoma recurrent 10025677 PTMalignant mesenchymoma 10061526 PTMalignant melanoma of sites other than skin 10025654 PTMalignant melanoma of eyelid 10063706 PTMalignant melanoma 10025650 PTMalignant mediastinal neoplasm 10061241 PTMalignant mast cell neoplasm 10025638 PTMalignant joint neoplasm 10078145 PTMalignant hydatidiform mole 10025598 PTMalignant histiocytosis 10025581 PTMalignant haemangiopericytoma recurrent 10025570 PTMalignant haemangiopericytoma 10025566 PTMalignant glioma 10065443 PTMalignant giant cell fibrous histiocytoma 10073141 PTMalignant genitourinary tract neoplasm 10074419 PTMalignant fibrous histiocytoma recurrent 10025561 PTMalignant fibrous histiocytoma of bone 10025557 PTMalignant fibrous histiocytoma 10025552 PTMalignant cranial nerve neoplasm 10061238 PTMalignant connective tissue neoplasm 10074340 PTMalignant anorectal neoplasm 10061237 PTLymphangiosarcoma 10025223 PTLung squamous cell carcinoma stage IV 10025125 PTLung squamous cell carcinoma stage III 10025124 PTLung squamous cell carcinoma stage II 10025123 PTLung squamous cell carcinoma stage I 10025122 PTLung squamous cell carcinoma stage 0 10025121 PTLung squamous cell carcinoma recurrent 10025120 PTLung neoplasm malignant 10058467 PTLung infiltration malignant 10062041 PTLung carcinoma cell type unspecified stage IV 10025070 PTLung carcinoma cell type unspecified stage III 10025069 PTLung carcinoma cell type unspecified stage II 10025068 PTLung carcinoma cell type unspecified stage I 10025067 PTLung carcinoma cell type unspecified stage 0 10025066 PTLung carcinoma cell type unspecified recurrent 10025065 PTLung adenocarcinoma stage IV 10025038 PTLung adenocarcinoma stage III 10025037 PTLung adenocarcinoma stage II 10025036 PTLung adenocarcinoma stage I 10025035 PTLung adenocarcinoma stage 0 10025034 PTLung adenocarcinoma recurrent 10025033 PTLung adenocarcinoma 10025031 PTLobular breast carcinoma in situ 10073099 PTLiver carcinoma ruptured 10050842 PTLiposarcoma recurrent 10024632 PTLiposarcoma 10024627 PTLip squamous cell carcinoma 10064055 PTMucinous cystadenocarcinoma ovary 10054914 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023887 Mucinous breast carcinoma 10073101 PT Mucinous adenocarcinoma of appendix 10073361 PT Mixed-type liposarcoma 10073136 PT Mixed hepatocellular cholangiocarcinoma 10027761 PT Mixed adenoneuroendocrine carcinoma 10076748 PT Metaplastic breast carcinoma 10073100 PT Extragonadal primary malignant teratoma 10061848 PT Extragonadal primary embryonal carcinoma 10015789 PT Ewing's sarcoma recurrent 10015564 PT Ewing's sarcoma 10015560 PT Erythroplasia of vulva 10052825 PT Lip neoplasm malignant stage unspecified 10024557 PT Lip and/or oral cavity cancer stage IV 10024540 PT Lip and/or oral cavity cancer stage III 10024539 PT Lip and/or oral cavity cancer stage II 10024538 PT Lip and/or oral cavity cancer stage I 10024537 PT Lip and/or oral cavity cancer stage 0 10024536 PT Lip and/or oral cavity cancer recurrent 10024535 PT Gastric cancer stage IV 10061967 PT Gastric cancer stage III 10017765 PT Gastric cancer stage II 10017764 PT Gastric cancer stage I 10017763 PT Gastric cancer stage 0 10017762 PT Gastric cancer recurrent 10017761 PT Gastric cancer 10017758 PT Ganglioneuroblastoma 10017708 PT Ganglioglioma 10017701 PT Gallbladder squamous cell carcinoma 10073068 PT Gallbladder cancer stage IV 10058283 PT Gallbladder cancer stage III 10058282 PT Gallbladder cancer stage II 10058281 PT Gallbladder cancer stage I 10059317 PT Gallbladder cancer stage 0 10059316 PT Gallbladder cancer recurrent 10017619 PT Gallbladder cancer 10017614 PT Gallbladder adenosquamous carcinoma 10073067 PT Gallbladder adenocarcinoma 10058286 PT Follicular thyroid cancer 10016935 PT Follicular dendritic cell sarcoma 10075332 PT Fibrosarcoma 10016632 PT Female reproductive tract carcinoma in situ 10061154 PT Fallopian tube cancer stage IV 10016187 PT Fallopian tube cancer stage III 10016186 PT Fallopian tube cancer stage II 10016185 PT Fallopian tube cancer stage I 10016184 PT Fallopian tube cancer 10016180 PT Extraskeletal osteosarcoma recurrent 10015852 PT Extraskeletal osteosarcoma 10015847 PT Extraskeletal myxoid chondrosarcoma 10073134 PT Extraskeletal chondrosarcoma recurrent 10015843 PT Extra-osseous Ewing's sarcoma recurrent 10015764 PT Extra-osseous Ewing's sarcoma 10015759 PT Extraocular retinoblastoma 10015831 PT Extragonadal primary seminoma (pure) stage IV 10015816 PT Extragonadal primary seminoma (pure) stage III 10015815 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023888 Extragonadal primary seminoma (pure) stage II 10015812 PT Erythroplasia of lip 10052826 PT Erythroblastosis 10049466 PT Epithelioid sarcoma recurrent 10015104 PT Epithelioid sarcoma 10015099 PT Epithelioid mesothelioma 10073064 PT Epiglottic cancer 10084056 PT Epididymal cancer 10073115 PT Ependymoma malignant 10014968 PT Ependymoma 10014967 PT Endotheliomatosis 10076868 PT Endometrial stromal sarcoma 10048397 PT Endometrial sarcoma recurrent 10067064 PT Endometrial sarcoma 10057649 PT Endometrial cancer stage IV 10014741 PT Endometrial cancer stage III 10014740 PT Endometrial cancer stage II 10014739 PT Endometrial cancer stage I 10014738 PT Endometrial cancer stage 0 10014737 PT Endometrial cancer recurrent 10014736 PT Endometrial cancer 10014733 PT Endometrial adenocarcinoma 10014720 PT Endocrine neoplasm malignant 10061122 PT Embryonal rhabdomyosarcoma 10065868 PT Ear neoplasm malignant 10055017 PT Ductal adenocarcinoma of pancreas 10073364 PT Desmoplastic small round cell tumour 10064581 PT Desmoplastic mesothelioma 10073063 PT Dermatofibrosarcoma protuberans 10057070 PT Dedifferentiated liposarcoma 10073135 PT Cystadenocarcinoma ovary 10054912 PT Craniopharyngioma 10011318 PT Conjunctival primary acquired melanosis 10066925 PT Conjunctival melanoma 10066384 PT Colorectal carcinoma stage 0 10010038 PT Colorectal cancer stage IV 10010035 PT Colorectal cancer stage III 10010034 PT Colorectal cancer stage II 10010033 PT Colorectal cancer stage I 10010032 PT Colorectal cancer recurrent 10010030 PT Colorectal cancer 10061451 PT Colorectal adenocarcinoma 10052360 PT Colon cancer stage IV 10009956 PT Colon cancer stage III 10009955 PT Colon cancer stage II 10009954 PT Colon cancer stage I 10009953 PT Mesothelioma malignant recurrent 10027411 PT Mesothelioma malignant 10027407 PT Meningioma malignant 10027193 PT Medulloblastoma recurrent 10066594 PT Medulloblastoma 10027107 PT Medullary thyroid cancer 10027105 PT Medullary carcinoma of breast 10027095 PT Malignant urinary tract neoplasm 10061272 PT Malignant transformation 10064912 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023889 Malignant splenic neoplasm 10026702 PT Iris melanoma 10073086 PT Invasive papillary breast carcinoma 10073098 PT Invasive lobular breast carcinoma 10073096 PT Invasive ductal breast carcinoma 10073095 PT Invasive breast carcinoma 10075713 PT Intraosseous angioma 10048846 PT Intraocular melanoma 10061252 PT Intraductal proliferative breast lesion 10073094 PT Intraductal papillary-mucinous carcinoma of pancreas 10073365 PT Intracranial meningioma malignant 10022770 PT Intracranial germ cell tumour 10073751 PT Intestinal adenocarcinoma 10051925 PT Inflammatory malignant fibrous histiocytoma 10073142 PT Breast cancer stage IV 10006202 PT Breast cancer stage III 10006201 PT Breast cancer stage II 10006200 PT Breast cancer stage I 10006199 PT Breast cancer recurrent 10006198 PT Breast cancer male 10061020 PT Breast cancer in situ 10006189 PT Sarcomatoid mesothelioma 10073065 PT Sarcoma uterus 10039497 PT Sarcoma of skin 10039495 PT Sarcoma 10039491 PT Salivary gland cancer stage IV 10039403 PT Salivary gland cancer stage III 10039402 PT Salivary gland cancer stage II 10039401 PT Salivary gland cancer stage I 10039400 PT Salivary gland cancer stage 0 10039399 PT Salivary gland cancer recurrent 10039398 PT Salivary gland cancer 10061934 PT Round cell liposarcoma 10073139 PT Rhabdomyosarcoma recurrent 10039027 PT Rhabdomyosarcoma 10039022 PT Rhabdoid tumour of the kidney 10039019 PT Rhabdoid tumour 10073334 PT Retroperitoneal cancer 10038977 PT Retinoblastoma 10038916 PT Retinal melanoma 10038878 PT Respiratory tract carcinoma in situ 10038724 PT Renal cell carcinoma stage IV 10038414 PT Renal cell carcinoma stage III 10038413 PT Renal cell carcinoma stage II 10038412 PT Renal cell carcinoma stage I 10038411 PT Renal cell carcinoma recurrent 10038410 PT Renal cell carcinoma 10067946 PT Renal cancer stage IV 10038394 PT Renal cancer stage III 10038393 PT Renal cancer stage II 10038392 PT Renal cancer stage I 10038391 PT Inflammatory carcinoma of the breast 10021980 PT Inflammatory carcinoma of breast stage IV 10021979 PT Inflammatory carcinoma of breast stage III 10021978 PT Rectosigmoid cancer stage 0 10038095 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023890 Rectosigmoid cancer recurrent 10038094 PT Rectosigmoid cancer 10038086 PT Rectal cancer stage IV 10038051 PT Rectal cancer stage III 10038050 PT Rectal cancer stage II 10038049 PT Rectal cancer stage I 10038048 PT Rectal cancer stage 0 10038047 PT Rectal cancer recurrent 10038046 PT Rectal cancer 10038038 PT Rectal adenocarcinoma 10038019 PT Prostate cancer stage IV 10036920 PT Prostate cancer stage III 10036919 PT Prostate cancer stage II 10036918 PT Prostate cancer stage I 10036917 PT Prostate cancer stage 0 10036912 PT Prostate cancer recurrent 10036911 PT Prostate cancer 10060862 PT Primitive neuroectodermal tumour 10057846 PT Penis carcinoma stage I 10034332 PT Penis carcinoma recurrent 10034331 PT Penile squamous cell carcinoma 10059631 PT Penile cancer 10034299 PT Parathyroid tumour malignant 10033965 PT Paranasal sinus and nasal cavity malignant neoplasm stage IV 10033860 PT Paranasal sinus and nasal cavity malignant neoplasm stage III 10033859 PT Paranasal sinus and nasal cavity malignant neoplasm stage II 10033858 PT Paranasal sinus and nasal cavity malignant neoplasm stage I 10033857 PT Paranasal sinus and nasal cavity malignant neoplasm stage 0 10033856 PT Paranasal sinus and nasal cavity malignant neoplasm recurrent 10033855 PT Paranasal sinus and nasal cavity malignant neoplasm 10061909 PT Paraganglion neoplasm malignant 10033791 PT Papillary thyroid cancer 10033701 PT Papillary serous endometrial carcinoma 10033700 PT Papillary renal cell carcinoma 10078493 PT Pancreatoblastoma 10073367 PT Pancreatic sarcoma 10055006 PT Pancreatic carcinoma stage IV 10059326 PT Pancreatic carcinoma stage III 10059323 PT Pancreatic carcinoma stage II 10059322 PT Pancreatic carcinoma stage I 10059321 PT Pancreatic carcinoma stage 0 10059320 PT Pancreatic carcinoma recurrent 10033613 PT Pancreatic carcinoma 10033609 PT Pancoast's tumour 10033572 PT Paget's disease of the vulva 10033369 PT Paget's disease of penis 10033365 PT Paget's disease of nipple 10033364 PT Ovarian stromal cancer 10065858 PT Ovarian low malignant potential tumour 10033268 PT Ovarian germ cell tumour mixed 10073259 PT Ovarian germ cell teratoma stage IV 10033249 PT Ovarian germ cell teratoma stage III 10033245 PT Ovarian germ cell teratoma stage II 10033241 PT Ovarian germ cell teratoma stage I 10033237 PT Ovarian germ cell teratoma 10073265 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023891 Ovarian germ cell polyembryoma stage IV 10033235 PT Ovarian germ cell polyembryoma stage III 10033231 PT Ovarian germ cell polyembryoma stage II 10033227 PT Ovarian germ cell polyembryoma stage I 10033223 PTOvarian germ cell polyembryoma 10073264 PTOvarian germ cell endodermal sinus tumour stage IV 10033221 PTOvarian germ cell endodermal sinus tumour stage III 10033220 PTOvarian germ cell endodermal sinus tumour stage II 10033219 PTOvarian germ cell endodermal sinus tumour stage I 10033218 PTOvarian germ cell endodermal sinus tumour 10073263 PTOvarian germ cell embryonal carcinoma stage IV 10033208 PTOvarian germ cell embryonal carcinoma stage III 10033204 PTOvarian germ cell embryonal carcinoma stage II 10033200 PTBreast cancer female 10057654 PTBreast cancer 10006187 PTBreast angiosarcoma 10072813 PTBrain teratoma 10068394 PTBrain stem glioma 10006143 PTBrain sarcoma 10073857 PTBrain neoplasm malignant 10006131 PTBorderline serous tumour of ovary 10073267 PTBorderline ovarian tumour 10006032 PTBorderline mucinous tumour of ovary 10073266 PTBone sarcoma 10006007 PTBone marrow tumour cell infiltration 10049556 PTBone giant cell tumour malignant 10073106 PTBone cancer 10005949 PTBladder transitional cell carcinoma stage IV 10066752 PTBladder transitional cell carcinoma stage III 10066754 PTBladder transitional cell carcinoma stage II 10066753 PTBladder transitional cell carcinoma stage I 10066751 PTBladder transitional cell carcinoma stage 0 10066749 PTBladder transitional cell carcinoma recurrent 10066750 PTBladder transitional cell carcinoma 10005084 PTBladder squamous cell carcinoma stage unspecified 10005081 PTBladder squamous cell carcinoma stage IV 10005080 PTBladder squamous cell carcinoma stage III 10005079 PTBladder squamous cell carcinoma stage II 10005078 PTBladder squamous cell carcinoma stage I 10005077 PTBladder squamous cell carcinoma stage 0 10005076 PTBladder squamous cell carcinoma recurrent 10005075 PTBladder cancer stage IV 10005012 PTBladder cancer stage III 10005011 PTBladder cancer stage II 10005010 PTBladder cancer stage I, without cancer in situ 10005009 PTBladder cancer stage I, with cancer in situ 10005008 PTBladder cancer stage 0, without cancer in situ 10005007 PTBladder cancer stage 0, with cancer in situ 10005006 PTBladder cancer recurrent 10005005 PTBladder cancer 10005003 PTBladder adenocarcinoma stage unspecified 10004992 PTBladder adenocarcinoma stage IV 10004991 PTBladder adenocarcinoma stage III 10004990 PTBladder adenocarcinoma stage II 10004989 PTBladder adenocarcinoma stage I 10004988 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023892 Bladder adenocarcinoma stage 0 10004987 PT Bladder adenocarcinoma recurrent 10004986 PT Biphasic mesothelioma 10073062 PT Bile duct squamous cell carcinoma 10004633 PT Bile duct cancer stage IV 10059376 PTBile duct cancer stage III 10059375 PTBile duct cancer stage II 10059374 PTBile duct cancer stage I 10059373 PTPostcricoid cancer 10036334 PTPoorly differentiated thyroid carcinoma 10076603 PTPolycythaemia vera 10036057 PTPleural sarcoma 10051950 PTPleural mesothelioma malignant recurrent 10035607 PTPleural mesothelioma malignant 10059518 PTPleural mesothelioma 10035603 PTPleomorphic malignant fibrous histiocytoma 10073143 PTPleomorphic liposarcoma 10073138 PTPlasmacytoma 10035484 PTPlasma cell myeloma recurrent 10073133 PTPlasma cell myeloma in remission 10073132 PTPlasma cell myeloma 10035226 PTPituitary neoplasm malignant recurrent 10057838 PTPinealoblastoma 10050487 PTPineal parenchymal neoplasm malignant 10061537 PTPineal germinoma 10035052 PTPharyngeal cancer stage IV 10034818 PTPharyngeal cancer stage III 10034817 PTPharyngeal cancer stage II 10034816 PTPharyngeal cancer stage I 10034815 PTPharyngeal cancer stage 0 10034814 PTPharyngeal cancer recurrent 10034813 PTPharyngeal cancer 10034811 PTPhaeochromocytoma malignant 10051710 PTPhaeochromocytoma crisis 10068778 PTPhaeochromocytoma 10034800 PTPeritoneal sarcoma 10051949 PTPeritoneal mesothelioma malignant recurrent 10034671 PTPeritoneal mesothelioma malignant 10056558 PTPeritoneal gliomatosis 10070561 PTPeripheral primitive neuroectodermal tumour of soft tissue 10073144 PTPeripheral primitive neuroectodermal bone tumour 10073107 PTPeripheral neuroepithelioma of soft tissue 10057646 PTPeripheral neuroepithelioma of bone recurrent 10034605 PTPeripheral neuroepithelioma of bone 10061342 PTNeurofibrosarcoma 10061527 PTPericardial mesothelioma malignant recurrent 10034480 PTPericardial mesothelioma malignant 10073066 PTPenis carcinoma stage IV 10034335 PTPenis carcinoma stage III 10034334 PTPenis carcinoma stage II 10034333 PTBile duct cancer stage 0 10059384 PTBile duct cancer recurrent 10004596 PTBile duct cancer 10004593 PTBile duct adenosquamous carcinoma 10004589 PTBile duct adenocarcinoma 10004585 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023893 Basosquamous carcinoma 10004178 PT Atypical teratoid/rhabdoid tumour of CNS 10065907 PT Astrocytoma malignant 10060971 PT Astrocytoma 10003571 PT APUDoma 10003069 PT Appendix cancer 10073360 PT Apocrine breast carcinoma 10066206 PT Angiosarcoma recurrent 10002480 PT Angiosarcoma non-metastatic 10057700 PT Angiosarcoma 10002476 PT Angiocentric glioma 10073129 PT Anaplastic thyroid cancer 10002240 PT Anaplastic oligodendroglioma 10073128 PT Anaplastic meningioma 10073127 PT Anaplastic astrocytoma 10002224 PT Anal squamous cell carcinoma 10073358 PT Anal cancer stage IV 10002138 PT Anal cancer stage III 10002137 PT Anal cancer stage II 10002136 PT Anal cancer stage I 10002135 PT Anal cancer stage 0 10002134 PT Anal cancer recurrent 10002133 PT Anal cancer 10061424 PT Alveolar soft part sarcoma recurrent 10001887 PT Alveolar soft part sarcoma 10001882 PT Alveolar rhabdomyosarcoma 10065867 PT Aesthesioneuroblastoma 10001433 PT Adrenocortical carcinoma 10001388 PT Adrenal gland cancer 10073152 PT Adenosquamous cell lung cancer stage IV 10001254 PT Adenosquamous cell lung cancer stage III 10001251 PT Adenosquamous cell lung cancer stage II 10001250 PT Adenosquamous cell lung cancer stage I 10001249 PT 090177e196edd21d\Final\Final On: 01-May-2021 00:12 (GMT) FDA-CBER-2021-5683-0023894